Whooping Cough clinical trials
The registry lists 290 studies for Whooping Cough across more than 10 countries. 23 are recruiting or about to start. 106 of them are mainly about Whooping Cough (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.
Get an email when these change. Save the Whooping Cough studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Status
Who runs them
Sanofi Pasteur, a Sanofi Company (62) · GlaxoSmithKline (43) · Sanofi (20) · National Institute of Allergy and Infectious Diseases (NIAID) (10) · LG Chem (7) · Merck Sharp & Dohme LLC (7) · St George's, University of London (5) · Mahidol University (5)
What is being tested here
Drugs under test in Whooping Cough studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 5
- Dec 2026Safety of Tetanus, Diphtheria, Acellular Pertussis With 5 Acellular Pertussis Components (Tdap5) Vaccination During Pregnancy · Sanofi
- Dec 2026Establishing a Controlled Human Infection Model of Pertactin-deficient Bordetella Pertussis · Dalhousie University
- Mar 2027Assessment of the Acceptability of, and Factors Associated With, Recommended Vaccinations During Pregnancy in Maternity Units in the Ile-de-France Region · Assistance Publique - Hôpitaux de Paris
- Aug 2027A Phase I/II Clinical Trial of the Diphtheria, Tetanus, Acellular Component Pertussis and Sabin Inactivated Poliomyelitis Vaccine Adsorbed · Institute of Medical Biology, Chinese Academy of Medical Sciences
- Oct 2027Safety and Immunogenicity of a Combined Diphtheria, Tetanus, Whole Cell Pertussis, Hepatitis B, Recombinant Poliomyelitis and Haemophilus Influenzae Type b (Hib) Vaccine (SIIPL DTwP-HepB-rPV-Hib) · Serum Institute of India Pvt. Ltd.
Who these studies take
Of the 13 Whooping Cough studies recruiting now, 2 (15%) set no upper age limit and 10 (77%) stop at 75 or younger. 9 (69%) take children under 18. 1 (8%) are for women only and 0 (0%) for men only; 10 (77%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 4 (31%) | 4 (31%) |
| 18 | 6 (46%) | 5 (38%) |
| 30 | 6 (46%) | 5 (38%) |
| 40 | 6 (46%) | 5 (38%) |
| 50 | 6 (46%) | 5 (38%) |
| 65 | 4 (31%) | 3 (23%) |
| 75 | 4 (31%) | 3 (23%) |
| 85 | 3 (23%) | 2 (15%) |
Across all 290 studies, recruiting or not: 78% stop at 75 or younger and 76% at 65; 74% take children; 13% are for women only and 1% for men only; 90% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Whooping Cough studies take
Of 26 phase 3 interventional studies under Whooping Cough, half reached primary completion within 15 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Phase 3 | 15 mo7–22 · 26 studies | 15 mo7–22 · 26 studies | — |
| Phase 4 | 22 mo8–34 · 22 studies | — | — |
| Interventional, no phase | 14 mo7–25 · 14 studies | — | — |
| Observational | 30 mo22–61 · 22 studies | — | — |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 13, 2026.
Newly registered3
- A Phase II Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (For Adults and Adolescents)Oct 26, 2026NCT07894055
- A Phase I/II Clinical Trial of the Diphtheria, Tetanus, Acellular Component Pertussis and Sabin Inactivated Poliomyelitis Vaccine AdsorbedOct 23, 2026NCT07891104
- Assessment of the Acceptability of, and Factors Associated With, Recommended Vaccinations During Pregnancy in Maternity Units in the Ile-de-France RegionOct 20, 2026NCT07882186
Studies
Recruiting first, then most recently updated. Showing 50 of 290. Browse all 290 → or search them.
- Safety and Immunogenicity of a Combined Diphtheria, Tetanus, Whole Cell Pertussis, Hepatitis B, Recombinant Poliomyelitis and Haemophilus Influenzae Type b (Hib) Vaccine (SIIPL DTwP-HepB-rPV-Hib)RecruitingNCT07855172Phase 1/21 country
- A Phase II Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (For Adults and Adolescents)RecruitingNCT07894055Phase 21 country
- A Phase I/II Clinical Trial of the Diphtheria, Tetanus, Acellular Component Pertussis and Sabin Inactivated Poliomyelitis Vaccine AdsorbedRecruitingNCT07891104Phase 1/21 country
- Assessment of the Acceptability of, and Factors Associated With, Recommended Vaccinations During Pregnancy in Maternity Units in the Ile-de-France RegionNot yet recruitingNCT078821861 country
- Study of BK1803 in Healthy InfantsNot yet recruitingNCT07793513Phase 31 country
- A Clinical Study on Immunogenicity Persistence of Adsorbed 5-component Acellular Pertussis, Diphtheria and Tetanus Combined VaccineNot yet recruitingNCT07744347
- Maternal Immunization With Tetanus Toxoid, Reduced Diphtheria Toxoid, Reduced-dose (2 µg) Recombinant Pertussis Vaccine (TdaP2gen) and Its Effect on the Immune Response in Thai Infants up to 15-18 Months OldNot yet recruitingNCT07621341Phase 41 country
- A Phase I Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (For Adults and Adolescents)Not yet recruitingNCT07492303Phase 1
- Phase I/II Clinical Trial of Diphtheria-Tetanus-Pertussis (Reduced Dose) VaccineNot yet recruitingNCT07418372Phase 1/21 country
- Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health PerspectiveRecruitingNCT073589101 country
- Establishing a Controlled Human Infection Model of Pertactin-deficient Bordetella PertussisRecruitingNCT06827470Phase 11 country
- Adsorption of Cell-free Diphtheria and Tetanus (Three-component) Combined With Vaccine Phase III Clinical TrialRecruitingNCT07112144Phase 31 country
- A Phase I/II Study to Evaluate the Safety and Immunogenicity of GC3111B in Healthy AdultsRecruitingNCT06997627Phase 1/21 country
- Study of Concomitant Administration of the sIPV and DTaP or MMRNot yet recruitingNCT06920069Phase 41 country
- Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of AgeNot yet recruitingNCT06618196Phase 2
- Safety and Immunogenicity of DTaP-IPV/Hib Pentavalent Vaccine in Chinese 2-month-old InfantsRecruitingNCT06605755Not applicable1 country
- The Optimal Timing of Vaccination in PregnancyRecruitingNCT064666291 country
- Impact of Bacterial Expression and Immune Response in the Severity of PertussisRecruitingNCT05897879Not applicable1 country
- Prevalence and Impact of Pertussis and RSV on Asthma Severity and ControlRecruitingNCT062860071 country
- Pediatric Pertussis in Ambulatory SettingsRecruitingNCT048077121 country
- Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined VaccineRecruitingNCT06184542Phase 11 country
- Knowledge of Pregnant Women Concerning Pertussis, Vaccination Against Pertussis and Cocooning StrategyNot yet recruitingNCT06114160
- A Study to Evaluate Safety and Immunogenicity of APV006 in Healthy AdultsNot yet recruitingNCT05952596Phase 1
- 10-year Follow-up After a Single Dose Acellular Pertussis VaccinationCompletedNCT06803524Phase 41 country
- A Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTpa) in Healthy Japanese Adolescents Aged 11 Years to <13 YearsCompletedNCT07596173Phase 31 country
- Establishing a Controlled Human Infection Model of Bordetella PertussisCompletedNCT05136599Phase 11 country
- Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary SeriesCompletedNCT05457946Phase 2/31 country
- A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary SeriesActive, not recruitingNCT06947499Phase 2/31 country
- A Clinical Trials of Adsorbed Cell-free DPT Vaccine (Five-component)CompletedNCT06708286Phase 2/31 country
- A Clinical Trial of Adsorbed Cell-free DPT Vaccine (5-component) (for People Aged 6 Years and Above)CompletedNCT06056050Phase 11 country
- Clinical Study to Assess the Immunogenicity and Safety of Hexavalent Vaccine Containing Reduced Dose IPVCompletedNCT06413121Phase 32 countries
- Pertussis Vaccination Among HIV-infected and HIV-uninfected Pregnant WomenCompletedNCT05264662Phase 41 country
- A Phase 4, Randomised Vaccination Study in Healthy Adults to Investigate the Effects of Acellular Pertussis Vaccine on Colonisation With Bordetella Pertussis Using Controlled Human InfectionActive, not recruitingNCT06903221Phase 41 country
- CARE-ID: Dynamics of Respiratory Infections in Children and Transmission in Households and SchoolsActive, not recruitingNCT066403871 country
- Safety of Tetanus, Diphtheria, Acellular Pertussis With 5 Acellular Pertussis Components (Tdap5) Vaccination During PregnancyActive, not recruitingNCT062580571 country
- Safety Monitoring of Boostagen® Vaccine in ThailandCompletedNCT074445021 country
- Study of BPZE1 (High Dose) Nasal Live Attenuated B. Pertussis VaccineCompletedNCT02453048Phase 11 country
- Safety Monitoring of VacPertagen Vaccine in ThailandCompletedNCT074001201 country
- Maternal Determinants of Infant Immunity to PertussisCompletedNCT05856396Phase 41 country
- Study of BK1301 (DTaP Vaccine) as a Booster in AdolescentsCompletedNCT02118961Phase 31 country
- Confirmatory Study of BK1310 in Healthy InfantsCompletedNCT03891758Phase 31 country
- First Adult Safety Trial on Nasal Live Attenuated B. Pertussis VaccineCompletedNCT01188512Phase 11 country
- Immunogenicity and Safety of BPZE1 Intranasal Pertussis Vaccine in Healthy School-age ChildrenCompletedNCT05116241Phase 23 countries
- Immunogenicity of a Combined Diphtheria-Tetanus-recombinant Acellular Pertussis (DTaP) Vaccine in Healthy ToddlersCompletedNCT07213089Phase 2/31 country
- Study Evaluating the Safety of a Recombinant Acellular Pertussis Vaccine in AdultsActive, not recruitingNCT06798831Phase 31 country
- Study Evaluating the Safety of a Recombinant Acellular Pertussis Vaccine in Pregnant WomenActive, not recruitingNCT068880761 country
- Study of DTwP-HepB-Hib-IPV (SHAN6™) Vaccine Administered Concomitantly With Routine Pediatric Vaccines to Healthy Infants and Toddlers in ThailandCompletedNCT04429295Phase 31 country
- A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, AdsorbedActive, not recruitingNCT05091619Phase 31 country
- Study to Evaluate the Immune Response After Booster Vaccination With Tdap-IPV Vaccine (Against Tetanus, Diphtheria, Pertussis and Poliomyelitis) in Children Who Received Different Pertussis Primary Vaccine Regimens in Republic of South AfricaCompletedNCT04300192Phase 41 country
- Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and InfantsCompletedNCT04398706Phase 24 countries